MediBeacon

Industry · 11 registered clinical trials — 4 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	Evaluation of Protein Loading on Measurement of Renal Reserve Glomerular Filtration Rate	N/A	2026-05-01
Not Yet Recruiting	MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure Glomerular Filtration Rate, Heart Failure	N/A	2026-04-01
Recruiting	Evaluation of Lumitrace for Visualizing Ureters During Abdominopelvic Surgeries Ureter Injury	Phase 1	2026-01-30
Recruiting	Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium Retinopathy, Retinal Vein Occlusion, Diabetic Retinopathy	EARLY_Phase 1	2025-11-06
Completed	Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGF Kidney Diseases, Kidney Injury, Kidney Failure	Phase 3	2023-03-20
Completed	Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Chronic Kidney Disease	Phase 3	2022-06-14
Completed	Oral Administration of MB-102 Versus Dual Sugar Testing for Gut Permeability Crohn Disease	EARLY_Phase 1	2019-10-27
Completed	Tolerability and Background Fluorescence of the MediBeacon Transdermal GFR Measurement System Acute Kidney Injury	N/A	2019-09-16
Completed	Pharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subject Acute Kidney Injury	Phase 2	2016-05-11
Completed	Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers Glomerular Filtration Rate, Acute Kidney Injury	Phase 1	2014-03-01
Completed	Pharmacokinetics of MP-3180 in Healthy Volunteers Glomerular Filtration Rate, Acute Kidney Injury	Phase 1	2013-11-01